The tumour volume was significantly reduced in mice either injected with Decitabine pre-treated Alb-R26Met HCC cells or when Decitabine pulses were administered to mice injected with untreated Alb-R26Met HCC cells (Fig. 2f–left). This evidence concerns the gene ALB and hepatocellular carcinoma.